Experiment: 7PH8

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.5 mM [U-100% 13C; U-100% 15N] IGF1Rtm, 100 mM [U-99% 2H] DPC, 0.3 mM sodium azide, 30 mM KH2PO4, 20 mM K2HPO4	95% H2O/5% D2O	0.1 M	6.7	AMBIENT Pa	313	Bruker AVANCE 600
2	2D 1H-15N TROSY	0.5 mM [U-100% 13C; U-100% 15N] IGF1Rtm, 100 mM [U-99% 2H] DPC, 0.3 mM sodium azide, 30 mM KH2PO4, 20 mM K2HPO4	95% H2O/5% D2O	0.1 M	6.7	AMBIENT Pa	313	Bruker AVANCE 600
3	2D 1H-13C CT HSQC	0.5 mM [U-100% 13C; U-100% 15N] IGF1Rtm, 100 mM [U-99% 2H] DPC, 0.3 mM sodium azide, 30 mM KH2PO4, 20 mM K2HPO4	95% H2O/5% D2O	0.1 M	6.7	AMBIENT Pa	313	Bruker AVANCE 600
4	2D 1H-13C HSQC	0.5 mM [U-100% 13C; U-100% 15N] IGF1Rtm, 100 mM [U-99% 2H] DPC, 0.3 mM sodium azide, 30 mM KH2PO4, 20 mM K2HPO4	95% H2O/5% D2O	0.1 M	6.7	AMBIENT Pa	313	Bruker AVANCE 600
5	3D CBCA(CO)NH	0.5 mM [U-100% 13C; U-100% 15N] IGF1Rtm, 100 mM [U-99% 2H] DPC, 0.3 mM sodium azide, 30 mM KH2PO4, 20 mM K2HPO4	95% H2O/5% D2O	0.1 M	6.7	AMBIENT Pa	313	Bruker AVANCE 600
6	3D HNCO	0.5 mM [U-100% 13C; U-100% 15N] IGF1Rtm, 100 mM [U-99% 2H] DPC, 0.3 mM sodium azide, 30 mM KH2PO4, 20 mM K2HPO4	95% H2O/5% D2O	0.1 M	6.7	AMBIENT Pa	313	Bruker AVANCE 600
7	3D HNCA	0.5 mM [U-100% 13C; U-100% 15N] IGF1Rtm, 100 mM [U-99% 2H] DPC, 0.3 mM sodium azide, 30 mM KH2PO4, 20 mM K2HPO4	95% H2O/5% D2O	0.1 M	6.7	AMBIENT Pa	313	Bruker AVANCE 600
8	3D HN(CO)CA	0.5 mM [U-100% 13C; U-100% 15N] IGF1Rtm, 100 mM [U-99% 2H] DPC, 0.3 mM sodium azide, 30 mM KH2PO4, 20 mM K2HPO4	95% H2O/5% D2O	0.1 M	6.7	AMBIENT Pa	313	Bruker AVANCE 600
9	3D HCCH-TOCSY	0.5 mM [U-100% 13C; U-100% 15N] IGF1Rtm, 100 mM [U-99% 2H] DPC, 0.3 mM sodium azide, 30 mM KH2PO4, 20 mM K2HPO4	95% H2O/5% D2O	0.1 M	6.7	AMBIENT Pa	313	Bruker AVANCE 600
10	3D 1H-15N NOESY	0.5 mM [U-100% 13C; U-100% 15N] IGF1Rtm, 100 mM [U-99% 2H] DPC, 0.3 mM sodium azide, 30 mM KH2PO4, 20 mM K2HPO4	95% H2O/5% D2O	0.1 M	6.7	AMBIENT Pa	313	Bruker AVANCE 600
11	2D 1H-13C HSQC aromatic	0.5 mM [U-100% 13C; U-100% 15N] IGF1Rtm, 100 mM [U-99% 2H] DPC, 0.3 mM sodium azide, 30 mM KH2PO4, 20 mM K2HPO4	95% H2O/5% D2O	0.1 M	6.7	AMBIENT Pa	313	Bruker AVANCE 600
12	3D 1H-13C NOESY aromatic	0.5 mM [U-100% 13C; U-100% 15N] IGF1Rtm, 100 mM [U-99% 2H] DPC, 0.3 mM sodium azide, 30 mM KH2PO4, 20 mM K2HPO4	95% H2O/5% D2O	0.1 M	6.7	AMBIENT Pa	313	Bruker AVANCE 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600

NMR Refinement
Method	Details	Software
simulated annealing		CYANA

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (target function)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CYANA		Guntert, Mumenthaler and Wuthrich
2	peak picking	CARA		Keller and Wuthrich
3	collection	TopSpin		Bruker Biospin
4	chemical shift assignment	CARA		Keller and Wuthrich
5	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
6	processing	TALOS		Cornilescu, Delaglio and Bax

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.